Nykredit Realkredit A/S
25.3.2021 18:30:29 CET | Globenewswire | Press release
To Nasdaq Copenhagen
25 March 2021
Nykredit Realkredit A/S – annual general meeting 2021
At Nykredit Realkredit's annual general meeting held on Thursday 25 March 2021
- The Annual Report 2020 and the proposal for distribution of profit, including distribution of dividend of DKK 2,230 million to Nykredit A/S, were approved.
- Discharge of the Board of Directors and Executive Board was adopted.
- The Board of Directors' proposals for remuneration policy, remuneration report and Management remuneration were adopted.
- Preben Sunke was elected a new member of the Board of Directors. Merete Eldrup, Nina Smith, Michael Demsitz, Per W. Hallgren, Jørgen Høholt, Hans-Ole Jochumsen and Vibeke Krag were re-elected to the Board of Directors. In addition, the Board of Directors includes four staff-elected members: Olav Bredgaard Brusen, Allan Kristiansen, Inge Sand and Kristina Andersen Skiøld.
- EY Godkendt Revisionspartnerselskab was appointed as the Company's auditors.
Immediately following the annual general meeting, the Board of Directors elected Merete Eldrup as its Chairman and Nina Smith as its Deputy Chairmen.
Copenhagen, 25 March 2021
Nykredit Realkredit A/S
Board of Directors
Contact:
Questions may be addressed to Press Relations, tel +45 20 37 28 69.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd18.9.2026 22:32:00 CEST | Press release
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients
Teva Pharmaceutical Industries Ltd18.9.2026 22:31:00 CEST | Press release
Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs
Teva Pharmaceutical Industries Ltd18.9.2026 22:30:00 CEST | Press release
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults
Leading Edge Materials Corp.18.9.2026 20:30:00 CEST | Press release
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2026 AND ANNOUNCES CLOSING OF THE SECOND TRANCHE OF PRIVATE PLACEMENT
Orion Oyj18.9.2026 18:00:00 CEST | Press release
Orion Corporation: Acquisition of own shares during week 38, 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
